aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet
RxNorm concept 308072, clinical drug (scd).
- RxCUI
- 308072
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/308072 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- aluminum hydroxide 160 MG (SCDC, consists of)
- magnesium carbonate 105 MG (SCDC, consists of)
- Chewable Tablet (DF, has dose form)
- aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet [Gaviscon] (SBD, has tradename)
- aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet [Acid Gone] (SBD, has tradename)
Linked data
NDCs
- 00363088078
- 00363110510
- 00363115510
- 11673081400
- 11822105000
- 11822105100
- 37808050510
- 37808051010
- 41250067510
- 46122015078
- 49035010510
- 51316015500
- 59779088078
- 63868099601
- 68016010510
- 68016018000
- 70000023401
- 76457000100
- 83324021901
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 308072 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/308072 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 308072. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.